Literature DB >> 31226666

Deep sequencing of 2009 influenza A/H1N1 virus isolated from volunteer human challenge study participants and natural infections.

Yongli Xiao1, Jae-Keun Park2, Stephanie Williams2, Mitchell Ramuta2, Adriana Cervantes-Medina3, Tyler Bristol3, Sarah Smith3, Lindsay Czajkowski3, Alison Han3, John C Kash2, Matthew J Memoli3, Jeffery K Taubenberger2.   

Abstract

Nasal wash samples from 15 human volunteers challenged with GMP manufactured influenza A/California/04/2009(H1N1) and from 5 naturally infected influenza patients of the 2009 pandemic were deep sequenced using viral targeted hybridization enrichment. Ten single nucleotide polymorphism (SNP) positions were found in the challenge virus. Some of the nonsynonymous changes in the inoculant virus were maintained in some challenge participants, but not in others, indicating that virus is evolving away from the Vero cell adapted inoculant, for example SNPs in the neuraminidase. Many SNP sites in challenge patients and naturally infected patients were found, many not identified previously. The SNPs identified, and phylogenetic analyses, showed that intrahost evolution of the virus are different in challenge participants and naturally infected patients. This study, using hybridization enrichment without PCR, provided an accurate and unbiased assessment of differential intrahost viral evolution from a uniform influenza inoculant in humans and comparison to naturally infected patients. Published by Elsevier Inc.

Entities:  

Keywords:  Deep-sequencing; Human challenge study; Influenza; Intrahost viral evolution

Mesh:

Substances:

Year:  2019        PMID: 31226666      PMCID: PMC6652224          DOI: 10.1016/j.virol.2019.06.004

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  69 in total

1.  ECHO: a reference-free short-read error correction algorithm.

Authors:  Wei-Chun Kao; Andrew H Chan; Yun S Song
Journal:  Genome Res       Date:  2011-04-11       Impact factor: 9.043

2.  Universal influenza B virus genomic amplification facilitates sequencing, diagnostics, and reverse genetics.

Authors:  Bin Zhou; Xudong Lin; Wei Wang; Rebecca A Halpin; Jayati Bera; Timothy B Stockwell; Ian G Barr; David E Wentworth
Journal:  J Clin Microbiol       Date:  2014-02-05       Impact factor: 5.948

3.  Coupling sensitive in vitro and in silico techniques to assess cross-reactive CD4(+) T cells against the swine-origin H1N1 influenza virus.

Authors:  Brian C Schanen; Anne S De Groot; L Moise; Matt Ardito; Elizabeth McClaine; William Martin; Vaughan Wittman; William L Warren; Donald R Drake
Journal:  Vaccine       Date:  2011-02-22       Impact factor: 3.641

4.  Mutation analysis of 2009 pandemic influenza A(H1N1) viruses collected in Japan during the peak phase of the pandemic.

Authors:  Jean-Étienne Morlighem; Shintaro Aoki; Mami Kishima; Mitsue Hanami; Chihiro Ogawa; Amadu Jalloh; Yukari Takahashi; Yuki Kawai; Satomi Saga; Eiji Hayashi; Toshiaki Ban; Shinyu Izumi; Akira Wada; Masayuki Mano; Megumu Fukunaga; Yoshiyuki Kijima; Masashi Shiomi; Kaoru Inoue; Takeshi Hata; Yukihiro Koretsune; Koichiro Kudo; Yuji Himeno; Aizan Hirai; Kazuo Takahashi; Yuko Sakai-Tagawa; Kiyoko Iwatsuki-Horimoto; Yoshihiro Kawaoka; Yoshihide Hayashizaki; Toshihisa Ishikawa
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

5.  Structural characterization of the 1918 influenza virus H1N1 neuraminidase.

Authors:  Xiaojin Xu; Xueyong Zhu; Raymond A Dwek; James Stevens; Ian A Wilson
Journal:  J Virol       Date:  2008-08-20       Impact factor: 5.103

6.  Using RRT-PCR analysis and virus isolation to determine the prevalence of avian influenza virus infections in ducks at Minto Flats State Game Refuge, Alaska, during August 2005.

Authors:  J A Runstadler; G M Happ; R D Slemons; Z-M Sheng; N Gundlach; M Petrula; D Senne; J Nolting; D L Evers; A Modrell; H Huson; S Hills; T Rothe; T Marr; J K Taubenberger
Journal:  Arch Virol       Date:  2007-06-01       Impact factor: 2.574

7.  A pan-H1 anti-hemagglutinin monoclonal antibody with potent broad-spectrum efficacy in vivo.

Authors:  Gene S Tan; Florian Krammer; Dirk Eggink; Alita Kongchanagul; Thomas M Moran; Peter Palese
Journal:  J Virol       Date:  2012-04-04       Impact factor: 5.103

8.  Evaluation of Preexisting Anti-Hemagglutinin Stalk Antibody as a Correlate of Protection in a Healthy Volunteer Challenge with Influenza A/H1N1pdm Virus.

Authors:  Jae-Keun Park; Alison Han; Lindsay Czajkowski; Susan Reed; Rani Athota; Tyler Bristol; Luz Angela Rosas; Adriana Cervantes-Medina; Jeffery K Taubenberger; Matthew J Memoli
Journal:  mBio       Date:  2018-01-23       Impact factor: 7.867

9.  Impact of age and pre-existing influenza immune responses in humans receiving split inactivated influenza vaccine on the induction of the breadth of antibodies to influenza A strains.

Authors:  Ivette A Nuñez; Michael A Carlock; James D Allen; Simon O Owino; Krissy K Moehling; Patricia Nowalk; Michael Susick; Kensington Diagle; Kristen Sweeney; Sophia Mundle; Thorsten U Vogel; Simon Delagrave; Moti Ramgopal; Richard K Zimmerman; Harry Kleanthous; Ted M Ross
Journal:  PLoS One       Date:  2017-11-01       Impact factor: 3.240

10.  Deep Sequencing of H7N9 Influenza A Viruses from 16 Infected Patients from 2013 to 2015 in Shanghai Reveals Genetic Diversity and Antigenic Drift.

Authors:  Yong-Li Xiao; Lili Ren; Xi Zhang; Jianwei Wang; Jeffery K Taubenberger; Li Qi; John C Kash; Yan Xiao; Fan Wu
Journal:  mSphere       Date:  2018-09-19       Impact factor: 4.389

View more
  5 in total

1.  Pre-existing immunity to influenza virus hemagglutinin stalk might drive selection for antibody-escape mutant viruses in a human challenge model.

Authors:  Jae-Keun Park; Yongli Xiao; Mitchell D Ramuta; Luz Angela Rosas; Sharon Fong; Alexis M Matthews; Ashley D Freeman; Monica A Gouzoulis; Natalia A Batchenkova; Xingdong Yang; Kelsey Scherler; Li Qi; Susan Reed; Rani Athota; Lindsay Czajkowski; Alison Han; David M Morens; Kathie-Anne Walters; Matthew J Memoli; John C Kash; Jeffery K Taubenberger
Journal:  Nat Med       Date:  2020-06-29       Impact factor: 53.440

2.  Safety and Efficacy of CR6261 in an Influenza A H1N1 Healthy Human Challenge Model.

Authors:  Alison Han; Lindsay Czajkowski; Luz Angela Rosas; Adriana Cervantes-Medina; Yongli Xiao; Monica Gouzoulis; Keith Lumbard; Sally Hunsberger; Susan Reed; Rani Athota; Holly Ann Baus; Amy Lwin; Jerald Sadoff; Jeffery K Taubenberger; Matthew J Memoli
Journal:  Clin Infect Dis       Date:  2021-12-06       Impact factor: 9.079

Review 3.  Controlled Human Infection Models To Accelerate Vaccine Development.

Authors:  Robert K M Choy; A Louis Bourgeois; Christian F Ockenhouse; Richard I Walker; Rebecca L Sheets; Jorge Flores
Journal:  Clin Microbiol Rev       Date:  2022-07-06       Impact factor: 50.129

4.  Establishment of a Pig Influenza Challenge Model for Evaluation of Monoclonal Antibody Delivery Platforms.

Authors:  Adam McNee; Trevor R F Smith; Barbara Holzer; Becky Clark; Emily Bessell; Ghiabe Guibinga; Heather Brown; Katherine Schultheis; Paul Fisher; Stephanie Ramos; Alejandro Nunez; Matthieu Bernard; Simon Graham; Veronica Martini; Tiphany Chrun; Yongli Xiao; John C Kash; Jeffery K Taubenberger; Sarah Elliott; Ami Patel; Peter Beverley; Pramila Rijal; David B Weiner; Alain Townsend; Kate E Broderick; Elma Tchilian
Journal:  J Immunol       Date:  2020-06-26       Impact factor: 5.422

5.  Insights into pathogenesis of fatal COVID-19 pneumonia from histopathology with immunohistochemical and viral RNA studies.

Authors:  Jennifer L Sauter; Marina K Baine; Kelly J Butnor; Darren J Buonocore; Jason C Chang; Achim A Jungbluth; Matthias J Szabolcs; Sejal Morjaria; Sharon L Mount; Natasha Rekhtman; Elena Selbs; Zong-Mei Sheng; Yongli Xiao; David E Kleiner; Stefania Pittaluga; Jeffery K Taubenberger; Amy V Rapkiewicz; William D Travis
Journal:  Histopathology       Date:  2020-10-16       Impact factor: 7.778

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.